English

More about this topic

Europe News

Who should pay for urban wastewater treatment?

The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to finance at least 80% of urban wastewater treatment.

Business

Bayer ordered to pay €1.9 billion by US court in Roundup cancer case

Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in 2018. However, it has since been hit with thousands of cancer-related Roundup cases.

Health news

5 takeaways on the Critical Medicines Act

From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at securing Europe's access to critical medicines.

Economy

Here’s why Trump’s tariffs could hit Ireland’s pharma sector hardest

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared to other EU economies.

ADVERTISEMENT

Health news

Big pharma urges Commission to slow down new critical medicines rules

With the date of publication for a Critical Medicines Act fast approaching, the EU’s pharma industry is urging the Commission to slow down rather than keeping to a promise made by Health Commissioner Oliver Várhelyi to launch the proposal within the first 100 days of his mandate.

Business

AstraZeneca reports strong results boosted by promising trials

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.

Business

Novo Nordisk reports positive next-generation obesity drug trial

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday.

Healthcare

Europe launches medicine shortage monitoring in 2025

Among the health policy novelties of 2025, a new tool developed by the European Medicines Agency (EMA) is set to harmonise monitoring of medicine shortages across Europe.

Business

Sanofi announces its largest China investment amid ongoing trade war

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer on.

Business

Bayer shares fall as pharma giant’s results fail to cheer investors

Bayer’s share price fell on Tuesday, following the company releasing lacklustre third quarter earnings with a warning that the current challenges may also impact next year’s results as well.

Business

AstraZeneca beats expectations and raises guidance despite China woes

AstraZeneca raises its fiscal 2024 guidance for the second consecutive quarter. This upgrade comes despite ongoing legal challenges in China as it reported robust third-quarter earnings results.

Business

CVC Capital Partners seeks cash injection for Italian pharma group

The private equity business is reported to be looking for a buyer to take on its majority stake in Genetic Group, an Italian pharmaceutical contract manufacturing company.

Business

European Commission fines MS drug maker Teva over improper patent use

The European Commission says it has fined the Israeli generic drug maker, Teva, more than €460m for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company's development of a competing medicine.

Business

Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R

The American private equity firm has agreed to French government demands about protecting jobs and investment in France.

Business

Sanofi unit bid: Group raises offer, pledging to save French jobs

The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the maker of France's best-selling drug.

Healthcare

Surging drug costs straining national budgets, health insurers warn

Rising pharmaceutical prices, particularly for novel therapies and cancer treatments, are driving increased health spending across Europe, placing significant strain on national budgets, according to a new study published this week.

Business

French minister says block to Sanofi deal is still 'on the table'

The potential sale of Opella, which produces Doliprane painkillers, is causing a headache in France.

Business

US private equity firm set to win Sanofi's consumer health division

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes over-the-counter medicine such as Doliprane and Allegra.

Business

GSK shares leap after drug firm settles US Zantac cancer claim lawsuit

GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies were not reliable.

Business

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.